Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03974737 · ClinicalTrials.gov registry record
CRI in POTS in Adolescents
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 77
- Enrollment target
NCT03974737 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 77 participants.
The verdict
NCT03974737 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 77 participants
- Enrollment target
Study Summary
The investigators aim to study whether the Compensatory Reserve Index (CRI) (an FDA approved device that assesses intravascular volume) can be used to evaluate severity of Postural Orthostatic Tachycardia Syndrome (POTS) and whether the CRI value has a correlation with severity of psychosocial symptoms and functional impairment associated with POTS.
Interventions
- DEVICE CRI device (non-invasive vitals sign measurement)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2019-06-01 |
| Est. Completion | 2020-09-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03974737
The ClinicalTrials.gov registry entry for NCT03974737 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 77 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CRI device (non-invasive vitals sign measurement) is the first listed.
NCT03974737 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03974737 about?
NCT03974737 is a clinical study titled "CRI in POTS in Adolescents". The investigators aim to study whether the Compensatory Reserve Index (CRI) (an FDA approved device that assesses intravascular volume) can be used to evaluate severity of Postural Orthostatic Tachycardia Syndrome (POTS) and whether the CRI value has a correlation with severity of psychosocial sympt...
What is the current status of trial NCT03974737?
This trial is currently completed. The enrollment target is 77 participants. The study started on 2019-06-01. Estimated completion is 2020-09-22.
What interventions are being tested in trial NCT03974737?
The interventions under investigation include: CRI device (non-invasive vitals sign measurement) (DEVICE).
Who is sponsoring clinical trial NCT03974737?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.